| __timestamp | MorphoSys AG | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9689000 | 1213000 |
| Thursday, January 1, 2015 | 10431000 | 3425000 |
| Friday, January 1, 2016 | 9618000 | 6311000 |
| Sunday, January 1, 2017 | 12348000 | 9518000 |
| Monday, January 1, 2018 | 28310241 | 28080000 |
| Tuesday, January 1, 2019 | 59336147 | 36550000 |
| Wednesday, January 1, 2020 | 159145941 | 46125000 |
| Friday, January 1, 2021 | 199800000 | 68486000 |
| Saturday, January 1, 2022 | 90225000 | 92032000 |
| Sunday, January 1, 2023 | 92538000 | 117532000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Rhythm Pharmaceuticals, Inc. and MorphoSys AG from 2014 to 2023. Over this period, MorphoSys AG's SG&A expenses surged by approximately 855%, peaking in 2021. Meanwhile, Rhythm Pharmaceuticals, Inc. exhibited a remarkable 9,600% increase, reaching its highest in 2023. Notably, Rhythm Pharmaceuticals, Inc. surpassed MorphoSys AG in 2023, with expenses 27% higher. This shift underscores the aggressive expansion and strategic investments by Rhythm Pharmaceuticals, Inc. in recent years. As the pharmaceutical landscape continues to shift, these financial insights provide a window into the strategic priorities and market positioning of these two industry giants.
Selling, General, and Administrative Costs: Eli Lilly and Company vs MorphoSys AG
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Selling, General, and Administrative Costs: MorphoSys AG vs HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: MorphoSys AG vs Novavax, Inc.
MorphoSys AG and Evotec SE: SG&A Spending Patterns Compared